The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

Sarah M. Lima, PhD, MPH, is an epidemiologist and postdoctoral fellow in cancer population at the Georgetown Lombardi ...

Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points ...

The editor in chief of Evidence-Based Oncology lauds Congress' authorization of a path for Medicare coverage for multicancer early detection. As this issue of Evidence-Based Oncology (EBO) went to ...

Study finds breast cancer survival gaps tied to historical redlining narrowed over time, though newer therapies may be widening disparities again.

Translating academic practices into a community oncology setting requires meaningful adaptations to successfully integrate practices like adoptive cell therapy, CAR-T therapies, or TCR-T therapies, ...

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...

Diabetes was associated with an increased risk of pancreatic cystic neoplasms (PCNs), with longer disease duration linked to progressively higher risk, according to a nationwide population-based ...

The combination of decitabine (DAC) and cytarabine, acclarithromycin, and granulocyte colony-stimulating factor (CAG) vs CAG alone showed greater efficacy among older patients with acute myeloid ...

The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...

New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care ...

New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care ...